SOSV

SOSV, a global multi-stage venture capital firm founded in 1995 in Cork, Ireland manages $1.5 billion in assets and has backed over 1,000 deep-tech startups across 60 countries through its flagship pre-seed programs HAX (hard tech/hardware) and IndieBio (life sciences), offering $250,000-$550,000 first checks annually alongside labs, mentorship, and demo days that fueled $6.5 billion in follow-on funding from 2021-2024.

Its key performance highlights include 60 first checks and 150 follow-ons annually, a diverse portfolio spanning climate, health, AI, robotics, and biotech, with notable exits such as Formlabs and BitMEX, as well as recent funds including $306M Fund V (2024) and $100M Select (2021). 

The firm’s “First Check in Deep Tech” strategy prioritizes human and planetary health through accelerators in New York, Newark, San Francisco, Shenzhen, and Tokyo, with spun-out entities such as dlab (blockchain) and Orbit Startups further enhancing its ecosystem. 

The fund’s mobile, Indian-focused investments include Puna Bio, working on cell therapies, and emerging ventures in clean tech and health tech, supported by the firm’s seed investments of around $250,000 to $550,000 through accelerator cohorts. Key exits globally, potentially impacting India’s ecosystem, include companies such as Formlabs, BitMEX, and Opentrons, highlighting SOSV’s focus on scaling transformative technologies with human and planetary health benefits.